Financials

  • Market Capitalization 1.83 B
  • Employee 110
  • Founded 2024
  • CEO N/A
  • Website www.inhibrx.com
  • Headquarter Delaware, United States
  • FIGI BBG01MS5Q9G3
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-10.67
市销率

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2032
MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock
7.30 USD-4.45%-21.17%+10.61%+211.97%1.90 B USD
2040
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.78 USD+1.40%-3.02%-1.87%+103.52%1.88 B USD
2060
SNDX
Syndax Pharmaceuticals, Inc. - Common Stock
20.53 USD+2.14%+3.58%+8.00%+27.36%1.83 B USD
2067
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.42 USD+2.70%-0.87%+12.87%-27.23%1.83 B USD

新闻